CLINICAL_TRIALS trial_result · 2024-08-15

Clinical Trial Update: Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

This clinical trial update investigates the immune response to COVID-19 in individuals with Type 1 diabetes and reports completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Cwm Taf University Health Board (NHS) | Conditions: SARS-CoV2 Infection Common Pathogens, Diabetes Mellitus, Type 1 | Status: COMPLETED